Inotiv (NOTVQ) Free Cash Flow Growth (1y) (2011 - 2026)
Inotiv (NOTVQ) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.28% |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn | 82.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.65% |
| Dec 31, 2025 | -18.50% |
| Sep 30, 2025 | 251.66% |
| Jun 30, 2025 | 40.43% |
| Mar 31, 2025 | -284.80% |
| Dec 31, 2024 | 26.09% |
| Sep 30, 2024 | -160.93% |
| Jun 30, 2024 | -2,333.80% |
| Mar 31, 2024 | 126.71% |
| Dec 31, 2023 | 23.21% |
| Sep 30, 2023 | 359.25% |
| Jun 30, 2023 | 96.90% |
| Mar 31, 2023 | 199.73% |
| Dec 31, 2022 | -132.11% |
| Sep 30, 2022 | -242.55% |
| Jun 30, 2022 | -958.47% |
| Mar 31, 2022 | -327.85% |
| Dec 31, 2021 | -3,919.10% |
| Sep 30, 2021 | -1.07% |
| Jun 30, 2021 | -378.73% |